“This increase in R-value is not just because of Delhi but also...
Category:
Pandemic
Latest
J&J pulls COVID vaccine sales forecast due to low demand, supply glut
Use of the shot has been weak in high-income countries, hurt by...
Health Ministry writes to states, UT over surge in COVID-19 cases
"Recently, there are a few States which are reporting a higher...
India approves Zydus Cadila’s ZyCoV-D vaccine for emergency use for adults and children above 12 yrs
Chairperson of the Zydus Group, Pankaj R Patel said, “We are extremely happy that our efforts to put out a safe, well-tolerated and efficacious vaccine to fight COVID-19 has become a reality with ZyCoV-D. To create the world’s first DNA vaccine at such a crucial juncture and despite all the challenges, is a tribute to the Indian research scientists and their spirit of innovation. I’d like to thank the Department of Biotechnology under the Government of India for their support in this mission of Atma Nirbhar Bharat and Indian Vaccine Mission COVID Suraksha.”
WHO seeks ‘best minds’ to probe new pathogens that jump from animals to humans
“In the last 20 years we’ve had many of these pathogens emerge or re-emerge: SARS, MERS, different avian influenzas, Zika, yellow fever and of course SARS-CoV-2,” van Kerkhove said.
RBI Guv pitches for continued policy support to revive growth, monitoring inflation
”The need of the hour is twofold: first, continue the monetary policy support to the economy; and second, remain watchful of any durable inflationary pressures and sustained price momentum in key components so as to bring back the CPI inflation to 4 per cent over a period of time in a non-disruptive manner,” he said.
Marsh and Citi develop innovative cover, to help speed global delivery of COVAX vaccines
The policy is underwritten by six leading insurers: AXA XL, Chubb, Liberty Specialty Markets, Sovereign Risk Insurance, Swiss Re Corporate Solutions, and Tokio Marine HCC.
Stephen Kay, Political Risk Leader, Marsh said: “Striving for greater global vaccine equity by increasing vaccination rates worldwide will not only help countries recover faster from the impact of the pandemic, but may also reduce the risk of new variants that come from high levels of community transmission. This innovative structure will hasten that process by allowing Gavi to procure and distribute vaccines more speedily and with greater financial confidence.”
Indian businesses suffer more cyber attacks with remote working
Despite being over a year into remote working and the possibility of a likely shift to hybrid working models, security remains a key concern for the Indian businesses, the report said, adding that managing security risks is undoubtedly getting more challenging in the country.
For respondents from India, malware (56 per cent) is the leading source of security attacks followed by ransomware (53 per cent), and phishing and credential stuffing (both 43 per cent).
Ayushman Bharat: Over 0.7 mn Covid treatments authorised from Apr’20-Jul’21
“Under the Ayushman Bharat health insurance scheme, over 20 lakh tests and 7.25 lakh COVID-19 related treatments worth over Rs 2,800 crore were authorised from April 2020 to July 2021.The insurance scheme allows the beneficiaries to avail free testing and treatment across all empanelled — both public and private — hospitals,” an official said.
Over 3.86 crore people didn”t get 2nd dose of Covid vaccines within stipulated time: Govt
According to information on the CoWIN portal, as of Thursday afternoon 44,22,85,854 people have received their first dose, while 12,59,07,443 have also taken their second.
Indian states preparing for next COVID wave focus on children
As of March 2021, less than 1 pct of India’s coronavirus deaths were in the under 15 age group, according to the health ministry, and officials say the severity of the disease in this age group has been minimal so far.India provides vaccines to people above the age 18. Most vaccines administered in India are made by AstraZeneca Plc, while shots produced by local manufacturer Bharat Biotech are also being used.
Pfizer, AstraZeneca vaccines less effective against Delta variant: Study
The researchers, however, noted that with Delta, Pfizer-BioNTech vaccine and Oxford-AstraZeneca preventive, known as Covishield in India, still offer good protection against new infections.
Two doses of either vaccine still provided at least the same level of protection as having had COVID-19 before through natural infection, they said.
US eases travel advisory for India
The Centre for Disease Control and Prevention (CDC) has now issued a Level 2 Travel Health Notice for India due to COVID-19, indicating a moderate level of COVID-19 in the country.
At the same time, the State Department urged Americans not to travel to Jammu and Kashmir (except the eastern Ladakh region and its capital, Leh) due to terrorism and civil unrest.